Tenet Healthcare Corporation company logo

# RNN 1st Gen Model Tenet Healthcare Corporation General medical & surgical hospitals

Prediction models:
62.50% successful of 56 deals
$ 19.28 Last close price
at 23-feb-2018
  • Top 20 Accuracy


Model's trade recommendations 6.11% Return for period

-1.45% Annual return

$1.96B Market Cap

β 1.24  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 6.11%
52wk return 2.97%
52wk Range
Sortino ratio -0.01
Sharpe ratio -0.01
Norm. RMSE 1.75%
Downside risk 14.82%
Volatility 17.86%
  • BUY Analysts consensus recommendation

Tenet Healthcare Corporation is a multinational investor-owned healthcare services company. At Tenet Healthcare, they have a longstanding commitment to serving patients, employees, physicians and partners. Tenet's Conifer Health Solutions subsidiary provides technology-enabled performance improvement and health management solutions to hospitals, health systems, integrated delivery networks, physician groups, self-insured organizations and health plans. Across their network of medical facilities, the Company's employees provide compassionate, quality care to millions of patients through a wide range of services: from wellness and primary care to chronic care management, urgent care, outpatient surgery, advanced diagnostics, rehabilitation and acute hospital care.

Industry sector: Medical

Sector classification: General medical & surgical hospitals

Deep Learning based analysis and prediction model for Tenet Healthcare Corporation (THC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for THC model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 98M
Shares Outstanding 101M
% Held by Insiders 3.10%
% Held by Institutions NaN%
EPS (last reported FY) $1.04
EPS (last reported Q) $-0.17
EPS, estimated (last reported Q) $-0.38
Total revenues $20 B
Net income $-0 B